FL115
Advanced Solid Tumors (combo with anti-PD-1)
Phase Ib/IIActive
Key Facts
Indication
Advanced Solid Tumors (combo with anti-PD-1)
Phase
Phase Ib/II
Status
Active
About Forlong Biotechnology
Clinical-stage biotech developing novel cytokine therapeutics for oncology using proprietary synthetic cytokine platforms.
View full company profileAbout Forlong Biotechnology
Clinical-stage biotech developing novel cytokine therapeutics for oncology using proprietary synthetic cytokine platforms.
View full company profile